Biochemical analysis of microbiotas obtained from healthy, prediabetic, type 2 diabetes, and obese individuals

Author:

Düzgün Çağla1ORCID,Dede Süreyya1ORCID,Karakuş Emine1ORCID,Adaş Mine2ORCID,Bilen Ömer3ORCID

Affiliation:

1. Department of Chemistry, Faculty of Arts and Sciences , Yildiz Technical University , Istanbul , Türkiye

2. Endocrinology and Metabolic Diseases Clinic , University of Health Sciences Okmeydanı Training and Research Hospital , Istanbul , Türkiye

3. Department of Urban and Regional Planning, Faculty of Architecture and Design , Bursa Technical University , Bursa , Türkiye

Abstract

Abstract Objectives In this study, we aimed to evaluate the intestinal and urinary microbiota diversity of obese, pre-diabetic, diabetic, and healthy subjects together with their food consumption frequency and investigate the effect on glucose metabolism. Methods DNA was isolated from stool and urinary samples of fifteen obese, fifteen prediabetics, fifteen type 2 diabetic, and fifteen lean participants by using the quantitative real-time polymerase chain reaction (qPCR) method. The amounts of Bifidobacterium, Bacteroides, and Firmicutes were measured and food consumption frequency was answered by all participants through a questionnaire. Results The levels of Bifidobacterium in fecal microbiota were significantly higher in type 2 diabetic patients compared with lean (p=0.034), prediabetic (p=0.009), and obese participants (p=0.012). However, the levels of Bifidobacterium in urinary microbiota were decreased in obese, prediabetic, and type 2 diabetic subjects as controls (p=0.048; p=0.038; p=0.015 respectively). Additionally, Bacteroides/Firmicutes ratio decreased in type two diabetic patients compared with lean subjects and had a negative correlation with BMI in prediabetic subjects. Food consumption frequency illustrates that lean subjects have unhealthy eating habits. Conclusions Urinary microbiota could be considered in the future context of a potential biomarker in the progress of type 2 diabetes and obesity.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3